To include your compound in the COVID-19 Resource Center, submit it here.

Ovasave: Phase IIb amended

TxCell amended the double-blind, placebo-controlled, European Phase IIb CATS29 trial to now evaluate a single IV injection of

Read the full 184 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE